PepsiCo Inc. says appetite-suppressing drugs haven’t affected sales of its snacks and sodas, though the company is focused on package size as it aims to reach its raised annual forecast.
PepsiCo Boosts Forecast as Sales Withstand Ozempic Threat
Related Posts
Quiet Platforms president leaves company
Shekar Natarajan is out as president of logistics provider Quiet Platforms. In a statement issued late Monday, the company said that Natarajan had exited the company, effective immediately. His departure was due to…
Trans-Pacific spot container shipping rates are inching up
Shipping lines have brought Asia-U.S. spot rates up off the floor, but it’s a slog: two steps up, one step back, another two steps up, a slide back again. The general rate increase (GRI) on Thursday was partially successful,…
RXO exec at UBS conference says 3PL’s market share still rising
NEW YORK — RXO’s chief strategy officer conceded to a conference here that he didn’t have much fresh to say in terms of the company’s market or overall outlook, but given the relative strength of the 3PL’s first-quarter…
Delta Cargo cranks up refrigeration at JFK airport
Delta Air Lines has inaugurated John F. Kennedy International Airport’s largest temperature-controlled facility for pharmaceuticals and perishable goods. The Atlanta-based carrier announced Thursday that it has doubled…
Nevada governor vetoes bill to restrict train lengths
Nevada Gov. Joe Lombardo has vetoed a bill that would have restricted the length of freight trains running through the state, saying such a mandate could violate federal interstate commerce laws. The Republican governor said…
TOP POSTS ON PRODUCE WIRE
